MERCOSUR: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in MERCOSUR

In 2022, after three years of growth, there was significant decline in the MERCOSUR human and animal blood market, when its value decreased by X% to $X. The total consumption indicated a temperate expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The level of consumption peaked at $X in 2021, and then fell in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in MERCOSUR

In value terms, human and animal blood production rose rapidly to $X in 2022 estimated in export price. The total production indicated a buoyant expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The pace of growth appeared the most rapid in 2020 when the production volume increased by X% against the previous year. As a result, production reached the peak level of $X. From 2021 to 2022, production growth remained at a somewhat lower figure.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in MERCOSUR

In 2022, after two years of decline, there was significant growth in overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume increased by X% to X tons. In general, exports showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2018 with an increase of X% against the previous year. The volume of export peaked at X tons in 2019; however, from 2020 to 2022, the exports remained at a lower figure.

In value terms, human and animal blood exports surged to $X in 2022. Over the period under review, exports, however, showed a mild slump. The pace of growth appeared the most rapid in 2020 when exports increased by X% against the previous year. Over the period under review, the exports reached the peak figure at $X in 2017; however, from 2018 to 2022, the exports failed to regain momentum.

Exports by Country

Argentina was the key exporting country with an export of around X tons, which finished at X% of total exports. It was distantly followed by Brazil (X tons), generating a X% share of total exports. Uruguay (X tons) held a relatively small share of total exports.

Argentina experienced a relatively flat trend pattern with regard to volume of exports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses. At the same time, Uruguay (X%) and Brazil (X%) displayed positive paces of growth. Moreover, Uruguay emerged as the fastest-growing exporter exported in MERCOSUR, with a CAGR of X% from 2012-2022. Brazil (X p.p.) significantly strengthened its position in terms of the total exports, while Argentina saw its share reduced by X% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Argentina ($X) remains the largest human and animal blood supplier in MERCOSUR, comprising X% of total exports. The second position in the ranking was taken by Brazil ($X), with a X% share of total exports.

In Argentina, human and animal blood exports decreased by an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Brazil (X% per year) and Uruguay (X% per year).

Export Prices by Country

In 2022, the export price in MERCOSUR amounted to $X per ton, which is down by X% against the previous year. In general, the export price continues to indicate a mild decline. The most prominent rate of growth was recorded in 2020 an increase of X%. The level of export peaked at $X per ton in 2017; however, from 2018 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Uruguay ($X per ton), while Argentina ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Argentina (X%), while the other leaders experienced a decline in the export price figures.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in MERCOSUR

In 2022, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were imported in MERCOSUR; falling by X% against the year before. Total imports indicated a mild increase from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 when imports increased by X%. Over the period under review, imports attained the maximum at X tons in 2021, and then fell in the following year.

In value terms, human and animal blood imports contracted notably to $X in 2022. Total imports indicated a mild expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2015 indices. The growth pace was the most rapid in 2021 when imports increased by X%. As a result, imports attained the peak of $X, and then fell rapidly in the following year.

Imports by Country

Brazil represented the major importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in MERCOSUR, with the volume of imports reaching X tons, which was approx. X% of total imports in 2022. Ecuador (X tons) held the second position in the ranking, distantly followed by Argentina (X tons) and Paraguay (X tons). All these countries together held near X% share of total imports. Chile (X tons), Peru (X tons) and Uruguay (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by Ecuador (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Brazil ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in MERCOSUR, comprising X% of total imports. The second position in the ranking was held by Argentina ($X), with an X% share of total imports. It was followed by Ecuador, with a X% share.

In Brazil, human and animal blood imports expanded at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Argentina (X% per year) and Ecuador (X% per year).

Import Prices by Country

The import price in MERCOSUR stood at $X per ton in 2022, falling by X% against the previous year. In general, the import price showed a relatively flat trend pattern. The growth pace was the most rapid in 2021 an increase of X%. As a result, import price reached the peak level of $X per ton, and then plummeted in the following year.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Chile ($X per ton), while Paraguay ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Peru (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :